From todays pps multiplied by 35 to 60 times. And it doesn't matter if this is otc, nyse, private whatever. I'm probably low balling. # of cases, cost to insurance, full market penetration. Yeah, I'm low balling. But you're asking a bit soon. Lets see it move towards final trials with positive results.